How To Diagnose And Treat An Inflammatory Optic Neuropathy?

Read full text Summarise with VIRAT
Authors: D. Bentabak, A. Chentouf
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Inflammatory optic neuropathies (ION) or optic neuritis are one of the most common and feared neurological symptoms, as they can compromise the visual functional prognosis of our often young patients and those of childbearing age. This optic neuritis sometimes constitutes one of the early and even unique signs of an autoimmune inflammatory pathology. All the interest is aroused to specify the clinical and evolutionary characteristics of this Optic Neuritis, and to perform radiological explorations (orbital, brain, and medullary imaging) and biological ones (study of cerebrospinal fluid and antibody assay), in order to move towards a possible inflammatory etiology, notably Multiple Sclerosis (MS), an Aqaporin 4 (AQP4) antibodies in optic Neuromyelitis (NMOSD with AQP4 antibodies), or a diseases with myelin oligodendrocyte glycoprotein antibodies (MOGAD). The early demonstration of a positive diagnosis and the rapid precision of the corresponding etiology will allow instant, sometimes aggressive, management based on high-dose corticoid boluses and/or repeated sessions of plasma exchange (PE)., especially in the case of NMOSD to AQP4 antibodies or MOGAD. The proposal of an adapted background treatment remains inevitable, with the aim of improving the functional prognosis of this condition and preventing relapses and disability in the long term

Fields of Study & Subjects

Multiple Sclerosis Research Studies Ocular Diseases and Behçet’s Syndrome Peripheral Neuropathies and Disorders

Publication details

Journal / source
IOSR Journal of Dental and Medical Sciences
Volume
25
Issue
1
Pages
73–79
Publication date
1 January 2026
Language
EN